Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015674 (
chronic fatigue syndrome
)
2,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Single nucleotide polymorphisms (SNP) in various genes have been described to be associated with susceptibility to autoimmune disease. In this study,
myalgic encephalomyelitis
/
chronic fatigue syndrome
(ME/
CFS
) patients and controls were genotyped for five immune gene SNPs in tyrosine phosphatase non-receptor type 22 (
PTPN22
, rs2476601), cytotoxic T-lymphocyte-associated protein 4 (
CTLA4
, rs3087243), tumor necrosis factor (
TNF
, rs1800629 and rs1799724), and
interferon regulatory factor 5
(
IRF5
, rs3807306), which are among the most important risk variants for autoimmune diseases. Analysis of 305 ME/
CFS
patients and 201 healthy controls showed significant associations of the
PTPN22
rs2476601 and
CTLA4
rs3087243 autoimmunity-risk alleles with ME/
CFS
. The associations were only found in ME/
CFS
patients, who reported an acute onset of disease with an infection (
PTPN22
rs2476601: OR 1.63, CI 1.04-2.55,
p
= 0.016;
CTLA4
rs3087243: OR 1.53, CI 1.17-2.03,
p
= 0.001), but not in ME/
CFS
patients without infection-triggered onset (
PTPN22
rs2476601: OR 1.09, CI 0.56-2.14,
p
= 0.398;
CTLA4
rs3087243: OR 0.89, CI 0.61-1.30,
p
= 0.268). This finding provides evidence that autoimmunity might play a role in ME/
CFS
with an infection-triggered onset. Both genes play a key role in regulating B and T cell activation.
...
PMID:Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset. 3232 64